Literature DB >> 21514240

Dietary treatments for epilepsy: management guidelines for the general practitioner.

Paul R Lee1, Eric H Kossoff.   

Abstract

As ketogenic diets become more frequently used as a standard treatment for epilepsy in children and adults, hospital and community neurologists, pediatricians, intensivists, general practitioners, and house officers will readily encounter patients who are receiving these dietary treatments. A growing body of evidence demonstrates that dietary therapies for epilepsy (classic ketogenic diet, medium-chain triglyceride diet, modified Atkins diet, and low-glycemic-index treatment) are highly effective, with approximately 30-60% of children overall having at least a 50% reduction in seizures after 6 months of treatment. However, as would be true of any other medical anticonvulsant therapy, these treatments have known side effects and complications requiring recognition and timely action. In addition, the ketogenic diet is a significant intervention requiring rigorous daily adherence; not every family is willing or able to make the necessary commitment to this therapy. We provide herein a survey of the most common situations faced in both the inpatient and outpatient settings, including a discussion of triage and management based on our center's experience as well as the recent 2009 International Consensus Guideline.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21514240     DOI: 10.1016/j.yebeh.2011.03.008

Source DB:  PubMed          Journal:  Epilepsy Behav        ISSN: 1525-5050            Impact factor:   2.937


  13 in total

1.  Electrolyte therapy reduces spike-and-wave discharges in the WAG/Rij rat model of absence epilepsy.

Authors:  Arkadij N Talnov; Elena Isaeva; Alina V Savotchenko; Galina V Dovgalets; Juan G Ochoa; Gregory L Holmes; Dmytro Isaev
Journal:  Epilepsy Behav       Date:  2012-06-28       Impact factor: 2.937

Review 2.  The changing face of dietary therapy for epilepsy.

Authors:  Ludovica Pasca; Valentina De Giorgis; Joyce Ann Macasaet; Claudia Trentani; Anna Tagliabue; Pierangelo Veggiotti
Journal:  Eur J Pediatr       Date:  2016-09-01       Impact factor: 3.183

3.  Antiepileptic drug selection for partial-onset seizures.

Authors:  Bassel F Shneker; Nathan B Fountain
Journal:  Curr Treat Options Neurol       Date:  2012-08       Impact factor: 3.598

Review 4.  Systematic review: isocaloric ketogenic dietary regimes for cancer patients.

Authors:  N Erickson; A Boscheri; B Linke; J Huebner
Journal:  Med Oncol       Date:  2017-03-28       Impact factor: 3.064

Review 5.  Harnessing the power of metabolism for seizure prevention: focus on dietary treatments.

Authors:  Adam L Hartman; Carl E Stafstrom
Journal:  Epilepsy Behav       Date:  2012-10-27       Impact factor: 2.937

6.  An update on the ketogenic diet, 2012.

Authors:  Ayelet Halevy; Lilach Peleg-Weiss; Roni Cohen; Avinoam Shuper
Journal:  Rambam Maimonides Med J       Date:  2012-01-31

Review 7.  Neurobiochemical mechanisms of a ketogenic diet in refractory epilepsy.

Authors:  Patricia Azevedo de Lima; Leticia Pereira de Brito Sampaio; Nágila Raquel Teixeira Damasceno
Journal:  Clinics (Sao Paulo)       Date:  2014-12       Impact factor: 2.365

8.  Efficacy of and patient compliance with a ketogenic diet in adults with intractable epilepsy: a meta-analysis.

Authors:  Fang Ye; Xiao-Jia Li; Wan-Lin Jiang; Hong-Bin Sun; Jie Liu
Journal:  J Clin Neurol       Date:  2015-01-02       Impact factor: 3.077

9.  Gluten- and casein-free dietary intervention for autism spectrum conditions.

Authors:  Paul Whiteley; Paul Shattock; Ann-Mari Knivsberg; Anders Seim; Karl L Reichelt; Lynda Todd; Kevin Carr; Malcolm Hooper
Journal:  Front Hum Neurosci       Date:  2013-01-04       Impact factor: 3.169

10.  Elemental changes in the hippocampal formation following two different formulas of ketogenic diet: an X-ray fluorescence microscopy study.

Authors:  J Chwiej; A Patulska; A Skoczen; K Janeczko; M Ciarach; R Simon; Z Setkowicz
Journal:  J Biol Inorg Chem       Date:  2015-11-04       Impact factor: 3.358

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.